BR112012002697A2 - method and incremental n-halamine water treatment device - Google Patents
method and incremental n-halamine water treatment deviceInfo
- Publication number
- BR112012002697A2 BR112012002697A2 BR112012002697A BR112012002697A BR112012002697A2 BR 112012002697 A2 BR112012002697 A2 BR 112012002697A2 BR 112012002697 A BR112012002697 A BR 112012002697A BR 112012002697 A BR112012002697 A BR 112012002697A BR 112012002697 A2 BR112012002697 A2 BR 112012002697A2
- Authority
- BR
- Brazil
- Prior art keywords
- species extract
- halamine
- incremental
- treatment device
- water treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/001—Processes for the treatment of water whereby the filtration technique is of importance
- C02F1/003—Processes for the treatment of water whereby the filtration technique is of importance using household-type filters for producing potable water, e.g. pitchers, bottles, faucet mounted devices
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/28—Treatment of water, waste water, or sewage by sorption
- C02F1/283—Treatment of water, waste water, or sewage by sorption using coal, charred products, or inorganic mixtures containing them
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/28—Treatment of water, waste water, or sewage by sorption
- C02F1/285—Treatment of water, waste water, or sewage by sorption using synthetic organic sorbents
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2303/00—Specific treatment goals
- C02F2303/18—Removal of treatment agents after treatment
- C02F2303/185—The treatment agent being halogen or a halogenated compound
Abstract
método para estimular o crescimento do cabelo. um método para estmular o crescimento do cabelo na cabeça humana, o qual comprende a administração simultânea: a) por via oral ou transdérmica de uma composição contendo um inibidor 5-alfa-redutase, ou um vasodilatador periférico, e b) por via tópica de uma composição contendo como ingrediente ativo, um extrato de espécies de allium, um extrato de espécies de citrus e - ou um extrato de espécies paullinia e um extrato de espécies de theobroma - ou um extracto de espécies de salix e sulfato de zinco.method to stimulate hair growth. a method for stimulating hair growth in the human head which comprises simultaneous administration: a) orally or transdermally of a composition containing a 5-alpha reductase inhibitor or peripheral vasodilator, and b) topically a a composition containing as an active ingredient an allium species extract, a citrus species extract and - or a paullinia species extract and a theobroma species extract - or a salix and zinc sulfate species extract.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23232909P | 2009-08-07 | 2009-08-07 | |
PCT/US2010/044893 WO2011017702A1 (en) | 2009-08-07 | 2010-08-09 | Enhanced n-halamine based water treatment method and device |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012002697A2 true BR112012002697A2 (en) | 2016-04-12 |
Family
ID=43544703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012002697A BR112012002697A2 (en) | 2009-08-07 | 2010-08-09 | method and incremental n-halamine water treatment device |
Country Status (2)
Country | Link |
---|---|
BR (1) | BR112012002697A2 (en) |
WO (1) | WO2011017702A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016036400A1 (en) * | 2014-09-04 | 2016-03-10 | Kx Technologies Llc | Countertop fluid dispenser |
US20220193633A1 (en) * | 2020-12-18 | 2022-06-23 | Auburn University | Use of polymeric beads to remove oxidative compounds from liquids |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0748223B1 (en) * | 1993-03-12 | 2002-02-06 | Auburn University | Polymeric cyclic n-halamine biocidal compounds |
US6129841A (en) * | 1999-03-10 | 2000-10-10 | Eagle Spring Filtration, Inc. | Portable water treatment assembly |
WO2008048749A2 (en) * | 2006-09-07 | 2008-04-24 | The Regents Of The University Of California | Biocidal fibers |
-
2010
- 2010-08-09 BR BR112012002697A patent/BR112012002697A2/en not_active IP Right Cessation
- 2010-08-09 WO PCT/US2010/044893 patent/WO2011017702A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011017702A1 (en) | 2011-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2010001260A1 (en) | Pharmaceutical composition comprising a salt of strontium and vitamin D and a cyclodextrin, where the mass ratio between the amount of vitamin D and the amount of cyclodextrin is between 1/40 and 1/800, useful for treating or preventing osteoporosis. | |
BRPI0518776A2 (en) | composition and method for oral care, and, methods for inhibiting inflammation in an oral tissue of a patient, and for promoting oral health in a patient. | |
BR112014010186A2 (en) | stable pharmaceutical formulation, kit, pharmaceutical composition, method for preparing a pharmaceutical formulation, and method for treating a human or animal | |
EA201101190A1 (en) | A PHARMACEUTICAL COMPOSITION INCLUDING LINAGLIPTIN AND OPTIONAL SGLT2 INHIBITOR AND ITS APPLICATION | |
BRPI0813450A2 (en) | COMPOUND, COMPOSITION, COMBINATION, PHARMACEUTICAL FORMULATION, AND METHODS TO INHIBIT AN ENZYME, TO EXTERMINE OR PREVENT GROWTH OF A MICROORGANISM, AND TO TREAT AND / OR PREVENT A DISEASE IN AN ANIMAL | |
DE602005024590D1 (en) | Phenothiazine derivative for wound healing | |
BR112015022514A2 (en) | compositions comprising selenium and their use for the treatment and prevention of disease or conditions associated with mitochondrial dysfunction | |
BRPI0919447B8 (en) | compounds derived from 1-amino-2-cyclobutylethylboronic acid, pharmaceutical composition and their use to treat cancer | |
HK1150027A1 (en) | Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method | |
BRPI0820568A2 (en) | Compound, pharmaceutical composition, use of a compound or pharmaceutical composition, and method of treating a human or animal | |
BR112014015482A8 (en) | phenyl carbamate compounds for use in the alleviation or treatment of pain and neuropathic pain | |
BR112013007343A2 (en) | methods for treating rosacea-associated erythema and for treating rosacea-associated telangiectasia; and, topical composition | |
BR112013017953A2 (en) | PHARMACEUTICAL COMPOSITION, TOPICAL FORMULATION, METHOD, AND PHOTOSENSITIZING COMPOSITION | |
BR112017010711A2 (en) | biostimulatory / crop growth regulating formulations and methods of use | |
WO2009150408A3 (en) | Topical antimuscarinic formulations | |
BR112015022590B8 (en) | A PHARMACEUTICAL COMPOSITION SUITABLE FOR TOPICAL APPLICATION TO THE SKIN AND/OR NAILS, ITS USE AND METHOD FOR IMPROVING THE STORAGE STABILITY OF A PHARMACEUTICAL COMPOSITION SUITABLE FOR TOPICAL APPLICATION TO THE SKIN AND/OR NAILS | |
WO2012017361A3 (en) | Method for stimulating hair growth | |
CA2904533C (en) | Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells | |
BR112012002697A2 (en) | method and incremental n-halamine water treatment device | |
UA104994C2 (en) | Sprayable composition containing red vine leaf extract | |
SI3057664T1 (en) | Use of a composition for the pigmentation of hair and hairs | |
MX341660B (en) | Ghrelin receptor agonist for treatment of dyscrasia. | |
MX2011007885A (en) | Narcotic emulsion formulations for treatment of cancer pain. | |
BRPI0712478B8 (en) | use of plant material or plant material extract | |
BR112014011336A2 (en) | pharmaceutical compositions comprising 7- (1h-imidazol-4-ylmethyl) -5,6,7,8-tetrahydro-quinoline for treating skin conditions and conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |